Literature DB >> 27683853

The urgent need for contemporary clinical trials in patients with asymptomatic carotid stenosis.

Seemant Chaturvedi1, Marc Chimowitz2, Robert D Brown2, Brajesh K Lal2, James F Meschia2.   

Abstract

Asymptomatic extracranial internal carotid artery atherosclerotic stenosis increases with age and is more common in men. Studies performed more than 2 decades ago showed that carotid endarterectomy reduced the rate of stroke in carefully selected patients with asymptomatic carotid stenosis compared with medical therapy in the long term. Those trials were completed more than 20 years ago and with advances in the treatment of atherosclerotic disease, the question has been raised to as to whether endarterectomy is still of value for patients with asymptomatic narrowing. Perioperative risk of carotid revascularization procedures has also declined. Due to improvements in both medical and surgical treatments for carotid artery stenosis, it is timely to reevaluate the efficacy of carotid intervention relative to medical treatment for patients with asymptomatic stenosis.
© 2016 American Academy of Neurology.

Entities:  

Mesh:

Year:  2016        PMID: 27683853      PMCID: PMC5123552          DOI: 10.1212/WNL.0000000000003267

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  55 in total

1.  Updated Society for Vascular Surgery guidelines for management of extracranial carotid disease.

Authors:  John J Ricotta; Ali Aburahma; Enrico Ascher; Mark Eskandari; Peter Faries; Brajesh K Lal
Journal:  J Vasc Surg       Date:  2011-09       Impact factor: 4.268

2.  High-dose atorvastatin after stroke or transient ischemic attack.

Authors:  Pierre Amarenco; Julien Bogousslavsky; Alfred Callahan; Larry B Goldstein; Michael Hennerici; Amy E Rudolph; Henrik Sillesen; Lisa Simunovic; Michael Szarek; K M A Welch; Justin A Zivin
Journal:  N Engl J Med       Date:  2006-08-10       Impact factor: 91.245

Review 3.  Carotid endarterectomy--an evidence-based review: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Authors:  S Chaturvedi; A Bruno; T Feasby; R Holloway; O Benavente; S N Cohen; R Cote; D Hess; J Saver; J D Spence; B Stern; J Wilterdink
Journal:  Neurology       Date:  2005-09-27       Impact factor: 9.910

4.  What is the current status of invasive treatment of extracranial carotid artery disease?

Authors:  A Ross Naylor
Journal:  Stroke       Date:  2011-06-09       Impact factor: 7.914

5.  Gender-associated differences in plaque phenotype of patients undergoing carotid endarterectomy.

Authors:  Willem E Hellings; Gerard Pasterkamp; Bart A N Verhoeven; Dominique P V De Kleijn; Jean-Paul P M De Vries; Kees A Seldenrijk; Theo van den Broek; Frans L Moll
Journal:  J Vasc Surg       Date:  2007-02       Impact factor: 4.268

6.  Effects of intensive medical therapy on microemboli and cardiovascular risk in asymptomatic carotid stenosis.

Authors:  J David Spence; Victoria Coates; Hector Li; Arturo Tamayo; Claudio Muñoz; Daniel G Hackam; Maria DiCicco; Janine DesRoches; Chrysi Bogiatzi; Jonathan Klein; Joaquim Madrenas; Robert A Hegele
Journal:  Arch Neurol       Date:  2009-12-14

7.  Strategies of clopidogrel load and atorvastatin reload to prevent ischemic cerebral events in patients undergoing protected carotid stenting. Results of the randomized ARMYDA-9 CAROTID (Clopidogrel and Atorvastatin Treatment During Carotid Artery Stenting) study.

Authors:  Giuseppe Patti; Fabrizio Tomai; Rosetta Melfi; Elisabetta Ricottini; Michele Macrì; Pietro Sedati; Arianna Giardina; Cristina Aurigemma; Mario Leporace; Andrea D'Ambrosio; Germano Di Sciascio
Journal:  J Am Coll Cardiol       Date:  2013-03-09       Impact factor: 24.094

8.  Precursors of extracranial carotid atherosclerosis in the Framingham Study.

Authors:  J S Fine-Edelstein; P A Wolf; D H O'Leary; H Poehlman; A J Belanger; C S Kase; R B D'Agostino
Journal:  Neurology       Date:  1994-06       Impact factor: 9.910

Review 9.  Screening for asymptomatic carotid artery stenosis: a systematic review and meta-analysis for the U.S. Preventive Services Task Force.

Authors:  Daniel E Jonas; Cynthia Feltner; Halle R Amick; Stacey Sheridan; Zhi-Jie Zheng; Daniel J Watford; Jamie L Carter; Cassandra J Rowe; Russell Harris
Journal:  Ann Intern Med       Date:  2014-09-02       Impact factor: 25.391

10.  Characterization of White Matter Injury in a Rat Model of Chronic Cerebral Hypoperfusion.

Authors:  Bo-Ryoung Choi; Dong-Hee Kim; Dong Bin Back; Chung Hwan Kang; Won-Jin Moon; Jung-Soo Han; Dong-Hee Choi; Kyoung Ja Kwon; Chan Young Shin; Bo-Ram Kim; Jongmin Lee; Seol-Heui Han; Hahn Young Kim
Journal:  Stroke       Date:  2015-12-15       Impact factor: 7.914

View more
  5 in total

Review 1.  Metabolic and Molecular Imaging of Atherosclerosis and Venous Thromboembolism.

Authors:  Eric A Osborn; Chase W Kessinger; Ahmed Tawakol; Farouc A Jaffer
Journal:  J Nucl Med       Date:  2017-04-27       Impact factor: 10.057

2.  MicroRNAs as Harbingers of High-Risk Carotid Artery Atherosclerotic Disease?

Authors:  Stefan Haemmig; Mark W Feinberg
Journal:  Circ Res       Date:  2017-02-17       Impact factor: 17.367

3.  Circulating inflammation-resolving lipid mediators RvD1 and DHA are decreased in patients with acutely symptomatic carotid disease.

Authors:  Hernan A Bazan; Yan Lu; Bokkyoo Jun; Zhide Fang; T Cooper Woods; Song Hong
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2017-08-26       Impact factor: 4.006

4.  Benefit of carotid revascularisation for women with symptomatic carotid stenosis: protocol for a systematic review.

Authors:  Olena Bereznyakova; Brian Dewar; Dar Dowlatshahi; Virginia Howard; Candyce Hamel; Sophia Gocan; Mark Fedyk; Michel Shamy
Journal:  BMJ Open       Date:  2019-11-11       Impact factor: 2.692

5.  Can risk modelling improve treatment decisions in asymptomatic carotid stenosis?

Authors:  James F Burke; Lewis B Morgenstern; Rodney A Hayward
Journal:  BMC Neurol       Date:  2019-11-22       Impact factor: 2.474

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.